AC Immune culls pipeline, lays off 30% of staff to extend cash runwaynews2025-09-04T14:07:31+00:00September 4th, 2025|Endpoints News|
Avadel’s $20M upfront for sleep drug; Congruence gets $32M for obesity drugnews2025-09-04T13:57:12+00:00September 4th, 2025|Endpoints News|
FDA delays decision on Agios drug in thalassemia over liver safetynews2025-09-04T13:48:24+00:00September 4th, 2025|Endpoints News|
Alacura raises $4M to coordinate medical transportationnews2025-09-04T13:00:50+00:00September 4th, 2025|Endpoints News|
Atlas Venture raises $400M to support existing portfolio biotechsnews2025-09-04T12:20:23+00:00September 4th, 2025|Endpoints News|
Enveda collects another $150M for I&I drug, sprawling pipeline of preclinical assetsnews2025-09-04T12:00:55+00:00September 4th, 2025|Endpoints News|
Sanofi’s stock takes a hit from subpar Phase 3 eczema datanews2025-09-04T11:26:52+00:00September 4th, 2025|Endpoints News|
Immunovant shares ‘unusual finding’ with first-gen FcRn drug in Graves’ diseasenews2025-09-04T10:58:35+00:00September 4th, 2025|Endpoints News|
Microbiome startup MRM Health nabs €55M Series B to run Phase 2b ulcerative colitis trialnews2025-09-04T05:00:41+00:00September 4th, 2025|Endpoints News|
Remedy Meds buys virtual health startup Thirty Madison for $500Mnews2025-09-03T20:35:54+00:00September 3rd, 2025|Endpoints News|
